FDA Alerts

skin infection
skin infection
08/08/2014
The FDA has approved oritavancin, an antibacterial drug to treat adults with acute bacterial skin and skin structure infections.
08/08/2014
Diabetes Q&A
Diabetes Q&A
08/04/2014
The FDA has approved a new tablet, empagliflozin, to improve glycemic control in adults with type 2 diabetes.
08/04/2014
COPD
COPD
08/01/2014
The FDA approved a once-daily, long-term olodaterol inhalation spray to treat patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema with airflow obstruction.
08/01/2014
FDA Alerts
FDA Alerts
07/14/2014
FDA
FDA
07/10/2014
The FDA has approved Kerydin, an alcohol-based solution, for the treatment of onychomycosis of the toenail.
07/10/2014
FDA Alerts
FDA Alerts
07/09/2014
Lymphoma
Lymphoma
07/08/2014
The FDA has approved two new drugs for the treatment of two rare conditions: peripheral T-cell lymphoma and Glanzmann's thrombasthenia.
07/08/2014
Lymphoma
Lymphoma
07/07/2014
Blood disorders
Blood disorders
07/03/2014
The FDA is mandating that manufacturers include a general warning on the drug labeling of all approved testosterone products to advise of the risk of blood clots.
07/03/2014
Diabetes Q&A
Diabetes Q&A
07/01/2014
An implant originally approved to treat certain patients with macular edema is now also approved for patients with diabetes.
07/01/2014